Prostatype Genomics AB (OSTO:PROGEN) Institutional Ownership : 0.02% (As of Jun. 11, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Prostatype Genomics AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Prostatype Genomics AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Prostatype Genomics AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Prostatype Genomics AB Institutional Ownership Historical Data

The historical data trend for Prostatype Genomics AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Institutional Ownership Chart

Prostatype Genomics AB Historical Data

The historical data trend for Prostatype Genomics AB can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.02	0.02	0.02	0.02	0.01	0.03	0.03	0.03	0.02	0.02

Prostatype Genomics AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines